[Guidelines for the treatment of childhood IgA nephropathy].

Norishige Yoshikawa(Takatsuki General Hospital), Mayumi Sako(National Center For Child Health and Development), Hitoshi Nakazato(Kumamoto University), Kenji Ishikura(Kitasato University), Koichi Kamei(National Center For Child Health and Development), Yoshitsugu Kaku(Fukuoka Children's Hospital and Medical Center for Infectious Diseases), Koichi Nakanishi, Tetsuya Kawamura, Yukari Yamamoto, Takashi Igarashi(National Center For Child Health and Development), Hidefumi Nakamura(National Center For Child Health and Development)
PubMed
January 1, 2008
Cited by 5

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135